Vietnam crab exportersoftshell crab exporter

All News Remdesivir In Focus Remdesivir BreakingNews of Remdesivir Your Interested Follow Story Remdesivir

Experts demand generic version of drug effective against Covid-19
SATURDAY, APRIL 10, 2021
Shouldn't a medicine like Remdesivir, which has proved to be life-saving in certain cases of Covid-19, be made available to all those who need it without delay?
FDA approves Gilead virus therapy remdesivir
FRIDAY, OCTOBER 23, 2020
The Food and Drug Administration approved Gilead Sciences Inc.'s antiviral therapy remdesivir on Thursday, making it the first drug to obtain formal clearance for treating the coronavirus.
Researchers identify 21 existing drugs that could treat Covid-19
SUNDAY, JULY 26, 2020
Researchers are currently testing all 21 compounds in small animal models and “mini lungs,” or lung organoids, that mimic the human tissue.
Covid-19 treatment remdesivir priced at $3,120 for the typical patient
MONDAY, JUNE 29, 2020
Gilead Sciences, the maker of the first covid-19 treatment found to have worked in clinical trials, said it will charge U.S. hospitals $3,120 for the typical patient with private insurance.
Taxpayers paid to develop remdesivir but will have no say when Gilead sets price
WEDNESDAY, MAY 27, 2020
The drug that buoyed expectations for a coronavirus treatment and drew international attention for Gilead Sciences, remdesivir, started as a reject, an also-ran in the search for antiviral drugs. Its path to relevance did not begin until Robert Jordan cleared it.
Remdesivir clinical trial in China shows no benefit for Covid-19 patients: WHO
FRIDAY, APRIL 24, 2020
Chula virologist appeals for blood plasma donations to treat Covid-19 patients
SATURDAY, APRIL 18, 2020
Covid-19 is a new disease caused by a virus, so there is no specific treatment, Dr Yong Poovorawan, an expert virologist at Chulalongkorn University, said while advocating the use of plasma to treat patients.
SET Index rises more than 3%, buoyed by anti-Covid drug
FRIDAY, APRIL 17, 2020
The Stock Exchange of Thailand (SET) Index closed at 1,239.24 today (April 17), up 39.09 points or 3.26 per cent.
SET rebounds on news of antiviral drug that tackles Covid-19
FRIDAY, APRIL 17, 2020
The Stock Exchange of Thailand (SET) Index rebounded by 26.85 points, or 2.24 per cent, to 1,227.00 in morning trade on Friday (April 17).